Literature DB >> 12083240

Risk of hepatitis C after immunoadsorption.

Rolf Kaiser1, Oliver Geulen, Bertfried Matz, Hans H Brackmann, Ulrich Spengler, Michael H Kramer, Martin Exner, Wilhelm Nettekoven, You-Dschun Ko, Heike Zeitler, Hans Vetter.   

Abstract

An episode of acute hepatitis in a patient with hemophilia during immunoadsorption therapy initially was misinterpreted as a reactivated hepatitis C virus (HCV) infection, but ultimately was shown to be an exogenous reinfection during cohort treatment with another HCV-positive patient. This incident illustrates that policies for the prevention of nosocomial transmission of blood-borne pathogens, especially in cohort treatment units, may need to be reassessed.

Entities:  

Mesh:

Year:  2002        PMID: 12083240     DOI: 10.1086/502063

Source DB:  PubMed          Journal:  Infect Control Hosp Epidemiol        ISSN: 0899-823X            Impact factor:   3.254


  1 in total

1.  Prevention of infection transmission during stem cell transplantation.

Authors:  M Bláha; P Mericka; V Stepánová; M Splino; J Malý; L Jebavý; P Zák; M Cermanová; S Filip; M Blazek; V Rehácek
Journal:  Folia Microbiol (Praha)       Date:  2006       Impact factor: 2.099

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.